The mission of the Tumor Imaging Metrics Core (TIMC) is to support clinical research investigators and patients enrolled in oncologic clinical trials evaluating novel therapies by facilitating the conduct of these trials, improving the quality and efficiency of tumor imaging assessments, and assisting with trial eligibility and continuing inclusion decisions and audits.
We work with numerous cancer care teams, clinical providers, and sponsors to ensure that accurate tumor metrics assessments are provided in a timely manner to support clinical trial decisions and help bring effective treatments to patients with cancer.